Interleukin-6 (IL-6) as a Predictor of Clinical Outcomes in Patients with COVID-19
Description
CONCLUSIONS: Study findings show that though IL-6 is an effective marker of inflammation and can be helpful for clinicians in recognizing patients with severe COVID-19. However, we still need further studies with larger sample size.
